leaderboard background final minSlide thumbnail
Vigene Biosciences offers research-grade and cGMP production of AAV, lentivirus, adenovirus, and plasmid that complies with FDA and EMA guidelines.

Excellence in Viral Vector-based Gene Delivery

AAV Gene Delivery

AAV

For tissue specificity and low immunogenicity in vivo.

AAV Packaging Services >
cGMP AAV Production >

Adenovirus Gene Delivery

Adenovirus

For a large packaging capacity and high transduction efficiency.

Adenovirus Packaging Services >
cGMP Adenovirus Production >

Lentivirus Gene Delivery

Lentivirus

For strong and stable gene expression.

Lentivirus Packaging Services >
cGMP Lentivirus Production >

Popular Services

Sign up for the Vigene Newsletter!

Join over 20,000 scientists who receive monthly updates about Vigene news, product releases, and promotions.
Viral Delivery Guide Revised

Viral Delivery Guide

Not sure which virus to use? Read our Viral Delivery Guide to find out which virus will work best for your specific applications.

Newsroom

February 27, 2020

Maryland Biotech Opens New Gene Therapy Contract Manufacturing Facility To Support Rapid Growth Grand Opening Event “Marks a Great Day” for Rare Disease Patients and Families, and a company in pursuit of a noble mission.

BioBuzz reported on the grand opening ceremony of Vigene Biosciences’s new, state-of-the-art 51,000 square foot cell and gene therapy manufacturing […]
February 27, 2020

Newsmakers: Vigene Biosciences Dr. Jeffrey Hung, Chief Commercial Officer, discusses Vigene’s new $20 million lab and strategic partnership with ASC Therapeutics

Contract Pharma talks with Dr. Jeffrey Hung, Chief Commercial Officer of Vigene Biosciences, about the strategic partnership, supporting manufacturing, and […]
February 27, 2020

Biosciences Facility Opens in Rockville, Striding to Help Cure Serious Diseases

MyMCMedia reported on the grand opening of Vigene Biosciences’s new 51,000-square-feet GMP viral vector manufacture facility. The $20 million, state-of-the-art […]
February 27, 2020

New bioscience company makes way to Montgomery County

I270 News (WDVM-TV) reported on the grand opening of Vigene Biosciences’s 51,000 square-feet new GMP manufacture facility. Vigene Biosciences’ mission […]
Partnership Vigene and Virovek colors

Vigene partners with Virovek for cGMP BAC-to-AAV production technology

Virovek has granted Vigene an exclusive cGMP license for their proprietary BAC-to-AAV production technology. AAV vectors generated from this scalable and efficient platform have been proven to infect and transduce a myriad of mammalian cell lines in vitro and a broad range of cell types in vivo.

Read More

Explore Resources

Technical Resources

Get the information you need from our guides and safety data sheets.

Explore Technical Resources >

Citations & Testimonials

Find out how scientists are using our products and services.

Explore Citations & Testimonials >

FAQs

Have a general or technical question? Start here first.

Explore FAQs >

Have questions?

Let’s find the product or service that meets your needs.

Talk to a Scientist